TuHURA Biosciences Statistics
Total Valuation
HURA has a market cap or net worth of $166.86 million. The enterprise value is $154.40 million.
Important Dates
The next estimated earnings date is Tuesday, May 20, 2025, before market open.
| Earnings Date | May 20, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
HURA has 43.68 million shares outstanding.
| Current Share Class | 43.68M |
| Shares Outstanding | 43.68M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | -44.58% |
| Owned by Insiders (%) | 41.54% |
| Owned by Institutions (%) | 8.53% |
| Float | 21.29M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 11.29 |
| P/TBV Ratio | 11.66 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.68, with a Debt / Equity ratio of 0.01.
| Current Ratio | 3.68 |
| Quick Ratio | 2.50 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -4.26 |
Financial Efficiency
Return on equity (ROE) is -332.67% and return on invested capital (ROIC) is -141.58%.
| Return on Equity (ROE) | -332.67% |
| Return on Assets (ROA) | -90.68% |
| Return on Invested Capital (ROIC) | -141.58% |
| Return on Capital Employed (ROCE) | -120.58% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.19M |
| Employee Count | 19 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -26.89% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -26.89% |
| 50-Day Moving Average | 3.42 |
| 200-Day Moving Average | 4.95 |
| Relative Strength Index (RSI) | 49.51 |
| Average Volume (20 Days) | 123,375 |
Short Selling Information
The latest short interest is 1.89 million, so 4.33% of the outstanding shares have been sold short.
| Short Interest | 1.89M |
| Short Previous Month | 1.92M |
| Short % of Shares Out | 4.33% |
| Short % of Float | 8.89% |
| Short Ratio (days to cover) | 6.08 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -17.65M |
| Pretax Income | n/a |
| Net Income | -22.65M |
| EBITDA | -17.53M |
| EBIT | -17.65M |
| Earnings Per Share (EPS) | -$1.21 |
Full Income StatementBalance Sheet
The company has $12.66 million in cash and $202,542 in debt, giving a net cash position of $12.45 million or $0.29 per share.
| Cash & Cash Equivalents | 12.66M |
| Total Debt | 202,542 |
| Net Cash | 12.45M |
| Net Cash Per Share | $0.29 |
| Equity (Book Value) | 14.59M |
| Book Value Per Share | 0.34 |
| Working Capital | 14.28M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$14.73 million and capital expenditures -$57,906, giving a free cash flow of -$14.79 million.
| Operating Cash Flow | -14.73M |
| Capital Expenditures | -57,906 |
| Free Cash Flow | -14.79M |
| FCF Per Share | -$0.34 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |